#Mexoryl #Ecamsule #Market #Size #Worth #Million
Portland, OR, Aug. 28, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global mexoryl SX (ecamsule) market generated $49.5 million in 2021, and is projected to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, frontrunners, and shareholders in introducing necessary strategies for the future and taking essential steps to significantly strengthen and heighten their position in the market.
Report Coverage & Details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $49.5 million |
| Market Size in 2031 | $82.6 million |
| CAGR | 5.3% |
| No. of Pages in Report | 199 |
| Segments Covered | Purity level, Application, and Region |
| Drivers | Increase in the standard of living |
| Growth of the online retail platform | |
| Opportunities | Surge in awareness towards skincare and beauty among people |
| Rise in concerns about skin protection against sun rays | |
| Restrains | Lack of awareness among consumers |
| Limited to specific consumers |
Download Sample PDF (199 Pages PDF with Insights): https://www.alliedmarketresearch.com/request-sample/17510
COVID-19 Scenario:
- The outbreak of COVID-19 has had a moderate impact on the growth of the global mexoryl SX (ecamsule) market, owing to the occurrence of lockdowns in various countries across the globe.
- Lockdowns resulted in the closure of various manufacturing facilities, including those of mexoryl SX (ecamsule), which adversely impacted its demand during the pandemic. Thus, there were disruptions in the supply chain for various personal hygiene and medical products.
- This was mainly due to the stringent social distancing restrictions imposed by the government to significantly curb the…
Read on GNW: Mexoryl SX (Ecamsule) Market Size Worth $82.6 Million by
